Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Geleen
Clinical trial register · Netherlands

Clinical Trials in Geleen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3171 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
3171
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1239 Rotterdam 853 Groningen 601 Nijmegen 565 Utrecht 543

Trials with a site in Geleen

16 of 3171 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
's-Hertogenbosch, Amsterdam, Arnhem, Breda, Dordrecht, Eindhoven, Enschede, Geleen
2025-08-05
Recruiting
[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer
NCT07018661Locally Advanced Gastric Adenocarcinoma, STOMACH NEOPLASM, Gastric Cancer, PET-CT
Leiden University Medical Center
Phase 2/3
250
Almelo, Amsterdam, Arnhem, Eindhoven, Geleen, Groningen, Leiden, Rotterdam
2025-07-03
Recruiting
Leiden University Medical Center
Phase 4
10,078
Apeldoorn, Geleen, Geldrop, Tilburg, Amsterdam, Naarden, Zwolle, Leiderdorp
2024-11-11
Not yet open
Amsterdam UMC, location VUmc
Observational
600
Arnhem, Geleen, Amsterdam
2024-10-15
Recruiting
Spinal Cord Monitoring in Multiple Sclerosis
NCT06827834Multiple Sclerosis
Zuyderland Medisch Centrum
Observational
155
Arnhem, Geleen, 's-Hertogenbosch, Dordrecht, Rotterdam
2024-08-06
Recruiting
Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures
NCT07380217High-risk PCI, Coronary Artery Disease Risk High
Amsterdam UMC, location VUmc
Not applicable
98
Amsterdam, Geleen, Groningen, Leiden, Maastricht, Nijmegen, The Hague, Utrecht
2024-01-25
Active, closed
Alfasigma S.p.A.
Observational
509
Amsterdam, Geleen, Nijmegen, Rotterdam, Tilburg, Utrecht
2023-06-12
Recruiting
AstraZeneca
Phase 3
4,300
Dirksland, Geleen, Groningen, Hoofddorp, Rotterdam
2023-03-31
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Amsterdam, Geleen, Nijmegen, Rotterdam, Tilburg, Uden, Utrecht
2023-01-16
Active, closed
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
NCT04754087Total Hip Arthroplasty, Degenerative Joint Disease of Hip, Avascular Necrosis of Hip, Rheumatoid Arthritis of Hip
Zimmer Biomet
Not applicable
300
Geleen, Hengelo
2021-07-07
Active, closed
Bayer
Phase 3
774
Geleen, Tilburg, Amsterdam, Hilversum, Hoofddorp, Dordrecht, The Hague
2020-10-20
Active, closed
European Myeloma Network B.V.
Phase 3
302
Alkmaar, Amersfoort, Amsterdam, Breda, Dordrecht, Geleen, Groningen, Leeuwarden
2020-09-25
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Eindhoven, Geleen, Nieuwegein, The Hague, Zaandam, Zwolle
2015-08
Active, closed
Acerta Pharma BV
Phase 3
533
Almere Stad, Amsterdam, Blaricum, Breda, Delft, Dordrecht, Geleen, Groningen
2015-07-28
Active, closed
AstraZeneca
Phase 3
1,837
Amsterdam, Breda, Geleen, Leiden, Maastricht, Rotterdam, Zaandam
2014-04-22
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/geleen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,171 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Geleen.

How many clinical trials are recruiting in Geleen?

7 of the 16 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Geleen), 16 studies
PhaseStudiesRecruitingShare
Phase 38250%
Observational3118.8%
Not applicable2112.5%
Phase 2116.3%
Phase 2/3116.3%
Phase 4116.3%

Most active sponsors

Lead sponsors with the most studies (Geleen)
Lead sponsorStudiesRecruiting
Amsterdam UMC, location VUmc21
AstraZeneca21
Leiden University Medical Center22
Abivax S.A.10
Acerta Pharma BV10
Alfasigma S.p.A.10
Alliance Foundation Trials, LLC.10
Bayer10
European Myeloma Network B.V.10
Stichting Hemato-Oncologie voor Volwassenen Nederland11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.